FOLH1 and neoplasm: Notably, the tumor uptake of 18F-(PEG)2-VS-PSMA and 18F-(PEG)3-VS-PSMA was nearly double that of the clinically approved 68Ga-PSMA-11 (Figure 15C-D), whereas comparable uptake was maintained in the muscles and kidneys 63.